Gregory Grunberg

Insider Reports History

Location
100 Beaver Street, Waltham, MA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Gregory Grunberg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Grunberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kala Pharmaceuticals, Inc. Director Common Stock 2.88M $19.4M $6.74 Jun 17, 2021 By Longitude Venture Partners II, L.P.
Kala Pharmaceuticals, Inc. Director Common Stock 2.53M $17.1M $6.74 Jun 17, 2021 By Longitude Venture Partners IV, L.P.
Kala Pharmaceuticals, Inc. Director Common Stock 40K $270K $6.74 Jun 17, 2021 Direct
89bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 27.4K Feb 9, 2023 Direct

Insider Reports Filed by Gregory Grunberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETNB 89bio, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director, 10%+ Owner
ETNB 89bio, Inc. May 16, 2022 1 $0 4 May 18, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director